Morgan Stanley’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $1.68M | Buy |
|
|||||
|
2018
Q4 | $8K | Buy |
|
|||||
|
2018
Q3 | $3K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $743K | Buy |
|
|||||
|
2016
Q3 | $45K | Buy |
|
|||||
|
2016
Q2 | $41K | Sell |
|
|||||
|
2016
Q1 | $386K | Buy |
|
|||||
|
2015
Q4 | $437K | Buy |
|
|||||
|
2015
Q3 | $173K | Sell |
|
|||||
|
2015
Q2 | $1.52M | Sell |
|
|||||
|
2015
Q1 | $1.63M | Buy |
|
|||||
|
2014
Q4 | $499K | Buy |
|
|||||
|
2014
Q3 | $391K | Sell |
|
|||||
|
2014
Q2 | $498K | Buy |
|
|||||
|
2014
Q1 | $249K | Buy |
|
|||||
|
2013
Q4 | $97K | Sell |
|
|||||
|
2013
Q3 | $1.4M | Buy |
|
|||||
|
2013
Q2 | $103K | Buy |
|